Afya Limited

Afya Limited(AFYA)の株式分析

$14.600

+0.010 (+0.07%)終値時点

Loading chart…
High
14.770
Open
14.650
VWAP
14.54
Vol
728.12K
Mkt Cap
1.53B
Low
14.260
Amount
10.59M
EV/EBITDA, TTM
2.03

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform.

AI analysis of Afya Limited (AFYA)

buy

Afya Ltd is a good buy right now due to its strong revenue growth of 8% in the latest earnings report, reaching BRL 1.013 billion, and a low forward P/E ratio of 7.13, indicating potential undervaluation. However, the main risk is the significant insider selling, which has increased by 1215.03% over the last month, suggesting potential concerns about the company's future performance.

バリュエーション指標

The current forward P/E ratio for Afya Limited (AFYA) is 7.13, compared to its 5-year average forward P/E of 11.29.

Forward P/E

Undervalued
5Y Average P/E
11.29
Current P/E
7.13
割高
14.41
割安
8.18

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
6.64
Current EV/EBITDA
2.03
割高
9.00
割安
4.28

Forward P/S

Strongly Undervalued
5Y Average P/S
2.20
Current P/S
0.30
割高
3.15
割安
1.25

Alphio AI Price Scenarios for AFYA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%AFYA

$28.55

シナリオ価格

B

Base

Base · 50%AFYA

$24.23

シナリオ価格

B

Bear

Bear · 25%AFYA

$20.66

シナリオ価格

Whales holding AFYA

S

SoftBank Group Corp.

+ HoldingAFYA

-39.89%

3M Return

イベントタイムライン

2026-08-24 (ET)

10:00:00

Afya and Yduqs Discuss Potential Business Combination

2025-11-12 (ET)

18:14:48

Afya announces Q3 adjusted EBITDA of R$398.9M, a 14.6% increase year-over-year

2025-11-07 (ET)

08:54:49

Afya Reveals Expansion of Medical Seats at ITPAC Porto Nacional

2025-08-13 (ET)

18:22:29

Afya still sees 2025 revenue R$3.67B-R$3.77B

18:21:04

Afya reports Q2 EPS R$2.27 vs. R$2.29 last year

ニュース

AFYA FAQ — answered by Alphio AI

Afya Ltd is a Brazil-based company engaged in the education sector. The Company is mainly focused on operating medical schools, offering health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine. In addition, the Firm provides degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. The Company's methodological approach combines integrated content, interactive learning, and an adaptive experience for learners. Through its educational content and technology-enabled activities, the Company focuses on personalized learning that mirrors one-on-one tutoring. The Company's undergraduate and graduate campuses are spread across Brazil, as well as its digital medical platform. It operates in the Academic & Educational Services sector.

Afya Ltd is a good buy right now due to its strong revenue growth of 8% in the latest earnings report, reaching BRL 1.013 billion, and a low forward P/E ratio of 7.13, indicating potential undervaluation. However, the main risk is the significant insider selling, which has increased by 1215.03% over the last month, suggesting potential concerns about the company's future performance.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める